ACBM | tickerfilter.com

Fundamental analysis

76%

Profitability 93%

Dept financing 25%

Liquidity 0%

Performance 90%

Performance

5 Days

0 0%

1 Month

0 0%

3 Months

0 0%

6 Months

0 0%

1 Year

0 0%

2 Year

0 0%

Key data

Stock price

N/A

P/E Ratio

N/A

DAY RANGE

N/A - N/A

EPS

N/A

52 WEEK RANGE

N/A - N/A

52 WEEK CHANGE

N/A

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

N/A

AVERAGE 30 VOLUME

N/A

Company detail

CEO:
Region: US
Website: acrobiomedicalco.com
Employees: 0
IPO year: 2018

Issue type:
Market: OTCM
Industry: Entertainment/Services – Amusement And Recreation
Sector: Services

Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. It sells cordycepin and cordceps powder, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc.

ACBM - ACRO BIOMEDICAL CO., LTD.